Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 3,7x - 4,1x | 3,9x |
| Selected Fwd Revenue Multiple | 3,4x - 3,8x | 3,6x |
| Fair Value | 1.360₹ - 1.492₹ | 1.426₹ |
| Upside | -5,7% - 3,5% | -1,1% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Gennex Laboratories Limited | 531739 | BSE:531739 |
| Morepen Laboratories Limited | MOREPENLAB | NSEI:MOREPENLAB |
| Alembic Pharmaceuticals Limited | APLLTD | NSEI:APLLTD |
| Unichem Laboratories Limited | UNICHEMLAB | NSEI:UNICHEMLAB |
| Medico Remedies Limited | MEDICO | NSEI:MEDICO |
| Cipla Limited | 500087 | BSE:500087 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| 531739 | MOREPENLAB | APLLTD | UNICHEMLAB | MEDICO | 500087 | |||
| BSE:531739 | NSEI:MOREPENLAB | NSEI:APLLTD | NSEI:UNICHEMLAB | NSEI:MEDICO | BSE:500087 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 9.0% | 17.1% | 9.6% | 7.6% | 8.2% | 9.4% | ||
| 3Y CAGR | 13.3% | 12.4% | 4.9% | 11.3% | 5.8% | 10.1% | ||
| Latest Twelve Months | 82.4% | 8.6% | 4.9% | 13.6% | 14.7% | 6.4% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 10.1% | 7.1% | 14.7% | -3.2% | 4.4% | 17.6% | ||
| Prior Fiscal Year | 6.2% | 3.9% | 7.7% | -11.6% | 4.9% | 17.8% | ||
| Latest Fiscal Year | 17.3% | 8.0% | 10.6% | -0.8% | 6.9% | 20.9% | ||
| Latest Twelve Months | 13.4% | 9.7% | 11.2% | 5.3% | 6.6% | 22.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 1.96x | 1.38x | 2.99x | 2.62x | 2.93x | 4.05x | ||
| EV / LTM EBIT | 14.6x | 14.2x | 26.8x | 49.6x | 44.3x | 18.3x | ||
| Price / LTM Sales | 2.09x | 1.47x | 2.85x | 2.56x | 2.86x | 4.36x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 1.38x | 2.62x | 2.99x | |||||
| Historical EV / LTM Revenue | 2.09x | 3.47x | 4.67x | |||||
| Selected EV / LTM Revenue | 3.73x | 3.93x | 4.13x | |||||
| (x) LTM Revenue | 267,201 | 267,201 | 267,201 | |||||
| (=) Implied Enterprise Value | 997,814 | 1,050,331 | 1,102,847 | |||||
| (-) Non-shareholder Claims * | 82,468 | 82,468 | 82,468 | |||||
| (=) Equity Value | 1,080,282 | 1,132,799 | 1,185,315 | |||||
| (/) Shares Outstanding | 807.6 | 807.6 | 807.6 | |||||
| Implied Value Range | 1,337.62 | 1,402.64 | 1,467.67 | |||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 1,337.62 | 1,402.64 | 1,467.67 | 1,441.70 | ||||
| Upside / (Downside) | -7.2% | -2.7% | 1.8% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 531739 | MOREPENLAB | APLLTD | UNICHEMLAB | MEDICO | 500087 | |
| Enterprise Value | 2,509 | 24,685 | 192,129 | 50,086 | 4,378 | 1,081,873 | |
| (+) Cash & Short Term Investments | 525 | 1,864 | 1,290 | 1,980 | 15 | 87,082 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (293) | (335) | (10,664) | (3,001) | (114) | (4,614) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 2,741 | 26,214 | 182,755 | 49,066 | 4,279 | 1,164,342 | |
| (/) Shares Outstanding | 227.4 | 548.0 | 196.6 | 70.4 | 83.0 | 807.6 | |
| Implied Stock Price | 12.05 | 47.84 | 929.75 | 696.90 | 51.57 | 1,441.70 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 12.05 | 47.84 | 929.75 | 696.90 | 51.57 | 1,441.70 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |